Alongside the injections, patients are encouraged to make healthy lifestyle adjustments that amplify the effectiveness of the treatment, leading to better long-term outcomes
In the STEP (Semaglutide Treatment Effect in People with Obesity) trials, Semaglutide injection demonstrated significant weight loss compared to placebo in individuals with obesity
The difference is hours, not days, so it primarily affects the acute post-injection experience rather than overall weekly efficacy
This video serves as a reminder that when it comes to nutrition and health, the quality and form of the supplement can be just as important as the quantity.
According to CNN, more than 70% of semaglutide prescriptions have gone to White patients White people are about four times more likely than Black people to have a prescription for a semaglutide medication, despite having nearly a 40% lower prevalence of diabetes and a 17% lower prevalence of obesity. So, White patients are receiving the vast majority of semaglutide prescriptions (Ozempic and Wegovy) by percentage, despite having a lower prevalence of both diabetes and obesity
